Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Cancer Chemotherapy and Biological Response Modifiers
|
August 23, 2005
Cancers of the large bowel and hepatobiliary tract
Tal Zaks, Weijing Sun
Current Topics in Microbiology and Immunology
|
July 29, 2022
Clinical Development of mRNA Vaccines: Challenges and Opportunities
Allison August, Luis Brito, Robert Paris, et al.
Nature Reviews. Materials
|
August 16, 2021
Lipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Robert Langer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2010
Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer
Hamouda Boussen, Massimo Cristofanilli, Tal Zaks, et al.
Investigational New Drugs
|
March 6, 2009
Target-specific randomized discontinuation trial design: a novel approach in molecular therapeutics
Matthew D Galsky, Tal Zaks, Habib Hassani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 7, 2021
mRNA-encoded, constitutively active STING<sup>V155M</sup> is a potent genetic adjuvant of antigen-specific CD8<sup>+</sup> T cell response
Sze-Wah Tse, Kristine McKinney, William Walker, et al.
Molecular Cancer Therapeutics
|
April 17, 2008
Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines
Joel Greshock, Jie Cheng, David Rusnak, et al.
The Lancet. Oncology
|
April 28, 2009
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study
Bella Kaufman, Maureen Trudeau, Ahmad Awada, et al.
Open Forum Infectious Diseases
|
July 7, 2022
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults
Allison August, Christine A Shaw, Heather Lee, et al.
Nature Medicine
|
December 10, 2021
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
Allison August, Husain Z Attarwala, Sunny Himansu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Cancer Chemotherapy and Biological Response Modifiers
|
August 23, 2005
Cancers of the large bowel and hepatobiliary tract
Tal Zaks, Weijing Sun
Current Topics in Microbiology and Immunology
|
July 29, 2022
Clinical Development of mRNA Vaccines: Challenges and Opportunities
Allison August, Luis Brito, Robert Paris, et al.
Nature Reviews. Materials
|
August 16, 2021
Lipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Robert Langer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2010
Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer
Hamouda Boussen, Massimo Cristofanilli, Tal Zaks, et al.
Investigational New Drugs
|
March 6, 2009
Target-specific randomized discontinuation trial design: a novel approach in molecular therapeutics
Matthew D Galsky, Tal Zaks, Habib Hassani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 7, 2021
mRNA-encoded, constitutively active STING<sup>V155M</sup> is a potent genetic adjuvant of antigen-specific CD8<sup>+</sup> T cell response
Sze-Wah Tse, Kristine McKinney, William Walker, et al.
Molecular Cancer Therapeutics
|
April 17, 2008
Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines
Joel Greshock, Jie Cheng, David Rusnak, et al.
The Lancet. Oncology
|
April 28, 2009
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study
Bella Kaufman, Maureen Trudeau, Ahmad Awada, et al.
Open Forum Infectious Diseases
|
July 7, 2022
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults
Allison August, Christine A Shaw, Heather Lee, et al.
Nature Medicine
|
December 10, 2021
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
Allison August, Husain Z Attarwala, Sunny Himansu, et al.
Page
of 3